SGMT
SGMT
NASDAQ · Biotechnology

Sagimet Biosciences Inc-A

$9.34
-0.60 (-6.04%)
As of Sep 29, 2:41 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 16 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target -67.9% upside
Low Target $2.20
Average Target $3.00
High Target $3.42
Current Price $9.34
Current
$9.34
Target
$3.00
$2.20 $3.00 avg $3.42
Scenario Analysis
Bear Case
$2.20
-76.4%
Low target
Base Case
$3.00
-67.9%
Avg target
Bull Case
$3.42
+-63.4%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$11.45
-18.4% from high
52-Week Low
$4.50
+107.6% from low
Target vs 52W High
$3.00
-73.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%